At-home EEG-based sleep monitoring in people living with Lennox-Gastaut syndrome: The HEADFIRST study.

Jay Pathmanathan¹, Franz Fürbass², Anna Marszalek², Sherry Ann Santarina², Michelle Fogerson², Tanja S Kellermann³, Jan Vandenneucker⁴, Matthew S Alkaitis², Jacob Donoghue²

¹Beacon Biosignals, Inc., Boston, MA, United States. Electronic address: jay.pathmanathan@beacon.bio.

²Beacon Biosignals, Inc., Boston, MA, United States.

³UCB, Smyrna, GA, United States.

⁴UCB, Brussels, Belgium.

PubMed DOI

Abstract

OBJECTIVES: Sleep dysfunction is a common but poorly characterized symptom in people living with Lennox-Gastaut syndrome (LGS). Sleep impairments exacerbate seizures while ictal activity causes sleep disturbance, leading to a cycle of sleep-epilepsy worsening. The HEADFIRST study was conducted to assess whether caregivers could self-operate a dry-electrode EEG headband (Waveband) to collect in-hom…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.